Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | BCG immunotherapy for bladder cancer--the effects of substrain differences. | Nat Rev Urol | 2013 | 1.60 |
2 | Planning percutaneous nephrolithotomy using multidetector computed tomography urography, multiplanar reconstruction and three-dimensional reformatting. | BJU Int | 2005 | 1.49 |
3 | The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer. | BJU Int | 2010 | 0.83 |
4 | Therapeutic options in the management of intermediate-risk nonmuscle-invasive bladder cancer. | BJU Int | 2008 | 0.78 |
5 | Corrigendum: BCG immunotherapy for bladder cancer--the effects of substrain differences. | Nat Rev Urol | 2015 | 0.75 |
6 | Editorial comment to Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group. | Int J Urol | 2010 | 0.75 |
7 | Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle. | Curr Opin Urol | 2018 | 0.75 |